Effects of Autologous Conditioned Serum on Non-Union After Open Reduction Internal Fixation Failure: A Case Series and Literature Review

<i>Background and Objectives</i>: Non-union is a severe complication of traumatic fracture that often leads to disability and decreased quality of life, with treatment remaining complex due to a lack of standardized protocols. This study examines the effectiveness of autologous condition...

Full description

Saved in:
Bibliographic Details
Main Authors: Pen-Gang Cheng, Man-Kuan Au, Chian-Her Lee, Meng-Jen Huang, Kuender D. Yang, Chun-Sheng Hsu, Chi-Hui Wang
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/60/11/1832
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:<i>Background and Objectives</i>: Non-union is a severe complication of traumatic fracture that often leads to disability and decreased quality of life, with treatment remaining complex due to a lack of standardized protocols. This study examines the effectiveness of autologous conditioned serum (ACS) for non-union in patients who have a failed open reduction internal fixation (ORIF). <i>Materials and Methods</i>: Eleven patients with confirmed non-union at least 9 months post-ORIF or total hip replacement were enrolled. These patients received ACS treatment on the lesion sites once to three times monthly and were followed up. Efficacy was monitored through monthly X-rays to assess callus formation and bone union. <i>Results</i>: Seven patients received ACS three times, three patients received it twice, and the one who underwent total hip replacement received it once. Ten patients achieved union at the last follow-up visit, indicating the effectiveness of ACS in non-union cases unresponsive to ORIF. ACS demonstrated promising results in facilitating bone union in these challenging cases. <i>Conclusions</i>: ACS has the potential as an alternative or adjective treatment for non-union and is worthy of being investigated further for the benefits of patients.
ISSN:1010-660X
1648-9144